Luntz, Steffen P <br/><br/>
HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].  [electronic resource] 

 -  BMC surgery  Aug 2005 
 - 18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2482 
<br/><br/><label>Standard No.: </label>10.1186/1471-2482-5-18  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine Transaminase--metabolism<br/>Aspartate Aminotransferases--metabolism<br/>Clinical Protocols<br/>Cyclosporine--adverse effects<br/>Cytoprotection--drug effects<br/>Double-Blind Method<br/>Glycine--administration & dosage<br/>Glycine Agents--administration & dosage<br/>Kidney Diseases--chemically induced<br/>Kupffer Cells--drug effects<br/>Liver Transplantation--mortality<br/>Multicenter Studies as Topic<br/>Postoperative Care<br/>Randomized Controlled Trials as Topic--methods<br/>Reperfusion Injury--diagnosis<br/>Research Design<br/>Survival Rate